Sun May 04 06:14:11 UTC 2025: ## Global COVID-19 Vaccination Efforts: A Retrospective

**NEW DELHI, INDIA – May 4, 2025** – Three years after the World Health Organization (WHO) declared a global health emergency, the COVID-19 pandemic is officially over. This declaration, made in May 2023, followed a massive global vaccination effort that saw over 13.64 billion doses administered worldwide. However, the legacy of this unprecedented campaign reveals both remarkable success and significant inequities.

While countries like Macau, Brunei, the UAE, and Qatar boasted vaccination rates exceeding 99%, others lagged considerably. Burundi (0.3%), Yemen (2.6%), and several African nations reported extremely low vaccination coverage, highlighting persistent challenges in vaccine access and hesitancy. Even in developed nations, vaccine hesitancy remained a significant factor, with a notable portion of the American population opting out of vaccination.

India, a major vaccine producer, reported over 2.2 billion doses administered by June 2024, achieving a 75% vaccination rate. However, the country’s vaccination tracker hasn’t been updated since, signifying a potential shift in data reporting priorities. China, the pandemic’s origin point, achieved high coverage with domestically produced vaccines but faced challenges with efficacy, particularly for older populations. Studies indicate that mRNA vaccines, like Pfizer and Moderna, proved more effective against severe illness in older individuals than the Chinese-developed inactivated vaccines.

The global vaccination drive, while initially rapid, slowed considerably in 2022 as most populations achieved sufficient immunity. The process was marked by vaccine hoarding in high-income countries, supply chain disruptions, and the need for sophisticated cold chain logistics to handle temperature-sensitive vaccines. India’s own experience, including a suspension of vaccine exports during a devastating Delta variant surge, underscored these logistical difficulties.

International collaborations, such as COVAX, played a crucial role in distributing vaccines to low and middle-income countries, but significant gaps in equitable access remained. While organizations like GAVI and WHO continue monitoring vaccine coverage and adapting strategies for future health emergencies, the COVID-19 vaccine has not yet become a standard part of routine immunization programs. Recent surveys reveal significant hesitancy regarding updated COVID-19 boosters, even among those recommended by health authorities.

Looking ahead, international efforts are focusing on pandemic preparedness and building resilient healthcare systems. The WHO’s recent agreement on a Pandemic Accord, alongside initiatives to diversify vaccine manufacturing, particularly in the Global South, signal a commitment to preventing future crises. However, the experience of the COVID-19 pandemic underscores the complex challenges of ensuring global health security and equitable access to essential resources.

Read More